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Mission




We value: service to the local, national and  
global community; integrity and ethical 
behavior; innovation and collaboration in 
research; professional practice and education; 
personal growth through lifelong learning; 
diversity and respect for all individuals; cultural 
competence.
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DEAN’S MESSAGE
As educators in a medical field, I’ve always felt that we in 
the College of Pharmacy serve more than the students who 
roam our halls. We are also dedicated to the world outside 
the University through our research and know that the work 
we produce in our labs at Avedisian Hall should have a 
lasting impact throughout the health system.
Looking back over the past year, it’s clear the College  
has made great strides in accomplishing both those goals 
— educating the next generation of pharmacists and 
pharmaceutical scientists, and making major contributions 
to the overall health of our society. The pages of this report 
detail just some of those accomplishments.
Perhaps nothing better exemplifies our commitment to 
innovation than the college being ranked 11th in the nation 
in federal research funding. We have made a concerted 
effort to invest in our research, a commitment that is 
continuing into the new academic year. Our professors are 
working on, innovative treatments to fight cancer, battle the 
devastating effects of alcohol use disorder, expand HIV 
treatment and prevention methods, and find ways to use 
natural, holistic methods to treat a host of ailments. 
The successes highlighted in the following pages are  
just a few of the ways our faculty members are working to 
impact the community. That same dedication is evident in 
the classroom, inspiring students to collaborate on projects 
and pursue their own innovations. Our students have 
received research awards of their own, been honored 
nationally for their service in the community, completed 
health services missions in foreign lands and lobbied state 
officials on important pharmaceutical issues. Our recent 
graduates have achieved impressive board pass rates, 
secured residency positions at a clip well above the  
national average, and nearly unanimously found 
employment immediately upon graduation.
The past few years have seen the College enhance its 
status as a leader in the pharmaceutical, biomedical and 
health industries, momentum that will continue in coming 
years. We hope you are as excited as we are to look back 
on the achievements of the past year and look forward to 
the major accomplishments to come.
–Dean E. Paul Larrat
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STUDENTS ENROLLED FOR FALL 2018
Pharm. D. by the numbers 
INCOMING CLASS OF 2024
B.S.P.S. by the numbers 
INCOMING CLASS OF 2022
Pharm. D.  
CLASS OF 2018
STUDENTS ARE FROM 
15 STATES
STUDENTS ARE FROM: 
6 STATES AND 2 FOREIGN 
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ANNUAL REPORT 2018 / 3
Baystate Medical Center, Springfield, MA
Boston Medical Center, Boston, MA
Cambridge Health Alliance, Cambridge, MA
Cape Regional Medical Center, Cape May Court House, NJ
CVS Health, Lincoln, RI
Department of Veterans Affairs Medical Center-Lebanon, 
Lebanon, PA
Eastern Maine Medical Center, Bangor, ME
Henry Ford Hospital, Detroit, MI
Holyoke Health Center Pharmacy, Holyoke, MA
Indian Health Service, Albuquerque Indian Health Center, 
Albuquerque, NM
Kaiser Permanente-San Diego, San Diego, CA
Kent County Memorial Hospital, Warwick, RI
Loma Linda University Health, Loma Linda, CA
Maine Medical Center, Portland, ME
Mercer University College of Pharmacy, Atlanta, GA
Rhode Island Hospital, Providence, RI
South County Health, Wakefield, RI
UMass Memorial Medical Center, Worcester, MA
UMass Medical School—Clinical Pharmacy Services, 
Shrewsbury, MA
UNC/D-Rex Pharmacy, Jonesville, NC
University Hospitals Portage Medical Center, Ravenna, OH
University of Rhode Island PGY1 Community, Kingston, RI
University of Rochester Medical Center, Rochester, NY
University of Vermont Medical Center, Burlington, VT
US Medical Affairs, Merck & Co, Inc., Kenilworth, NJ
Veterans Affairs Connecticut Healthcare System,  
West Haven, CT
Veterans Affairs Maine Healthcare System, Augusta, ME
Veterans Affairs Nebraska-W. Iowa Health Care  
System-Grand Island, NE
Veterans Affairs New Jersey Health Care System,  
East Orange, NJ
VA Tennessee Valley Healthcare System, Nashville, TN
Veterans Affairs Medical Center-Washington, Washington, D.C.
Veterans Health Care System of the Ozarks, Fayetteville, AR
Western New England University/CoP—Big Y, Springfield, MA
Wolfson Children’s Hospital/Baptist Health, Jacksonville, FL
URI Success Rate: 80%  National Average: 65%
Residency Placements
The URI College of Pharmacy consistently ranks among the top pharmacy schools in the 
country for post-graduate residency matches. The Class of 2018 has achieved an overall 
success rate of 80 percent, outpacing the national average of 65 percent, according to the 
American Society of Health-System Pharmacists. 
URI students have been placed in the following locations:  
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RESEARCH
Dynamic Faculty, Students fuel 
Scientific Breakthroughs
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College Ranked 11th nationally in Federal Research Funding
The University of Rhode Island College of Pharmacy is now ranked 11th in the nation in 
total federal research grant funding after securing nearly $12 million in federal funds in 
fiscal 2017, the latest year for which numbers are available. That ranking — of 138 
pharmacy colleges nationwide — is a record for URI.
URI is now the number 1 ranked pharmacy 
college in the Northeast in terms of federal 
research funding, primarily from the National Insti-
tutes of Health, and number 2 on the East Coast. 
Only the University of North Carolina at Chapel 
Hill ranked higher on the list.
The College had consistently ranked in the 20s 
for the preceding five-year period prior to 2017. A 
dynamic faculty focused on scientif-
ic breakthroughs, along with a 
concerted effort to increase grant 
funding and research partnerships, 
contributed to the move up the 
ranks, according to Dean E. Paul Larrat. 
“Many of our faculty members are in the middle, 
the primes, of their research careers and they’re 
really hitting their stride,” Larrat said, noting he 
expects the College will maintain the momentum 
going forward. “These successful, seasoned 
researchers are also mentoring our younger 
professors, whose new research funding isn’t 
even reflected in the 2017 rank. That’s what 
makes this sustainable.”
A committee of researchers, led by Professors 
Navindra Seeram, Kerry LaPlante, Bongsup Cho 
and Angela Slitt meet regularly to strategize 
research efforts and target grant funding. 
LaPlante recently held a grant funding workshop, 
teaching researchers in the Colleges of 
Pharmacy, Nursing and Health Sciences as well 
as the R.I. Idea Network of Biomedical Research 
Excellence (INBRE) program tips on writing grant 
applications. Slitt is chairwoman on the URI 
Council for Research Grants Program, serving as 
a university-wide advocate for grant funding.
The funding fuels critical research in such areas 
as drug development, cancer treatment and 
prevention, health outcomes, neurological health 
and the use of natural ingredients like maple in 
maintaining health, among a host of other 
important subjects. The benefit to the community 
of such scientific breakthroughs is obvious, but 
the grant funding also helps the College continu-
ally improve its educational offerings.
“We harp on our students to make a difference, 
and they see our faculty members doing just 
that,” Larrat said. “Being able to take salient 
discoveries from the research labs and bring that 
work into the classrooms is of benefit to our 
students; it makes us better teachers, and it 
makes our students better scientists and health 
providers. The access to work in those labs is 
incredibly valuable to our students. And it is 
translated into helping the patients we all serve.” 
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Drug Study Produces ‘Promising 
Therapy’ for Alcohol Use Disorder
Alcohol use disorder is among the leading causes of 
preventable death in the United States, killing more than 
88,000 people a year, according to the Centers for Disease 
Control, more than HIV/AIDS, gun violence and car crashes 
combined. Despite this, the current medications available to 
treat alcohol use disorder are not highly effective.
A URI College of Pharmacy Professor is focusing on  
changing that. Fatemah Akhlaghi, PharmD, PhD, is part of a 
team working to develop a novel medication to treat the 
disorder. Funded by a $1.65 million grant from the National 
Center for Advancing Translational Sciences, a branch of 
the National Institutes of Health (NIH), Akhlaghi’s team at 
URI is testing the safety and efficacy of a drug originally 
developed by Pfizer to treat obesity and diabetes. 
The drug focuses on ghrelin, a peptide with 28-amino acids 
that stimulates appetite and food intake. Known as “the 
hunger hormone,” ghrelin levels and feelings of hunger 
increase in tandem. In those suffering from alcohol use 
disorder, higher concentrations of ghrelin are associated 
with higher alcohol craving and consumption. The research-
ers believe an oral medication that blocks ghrelin may help 
stave off the cravings for alcohol. The initial study has 
shown positive results in lab rats and in 12 patients who 
volunteered for a study at NIH. The result of this study was 
published in May 2018 in Molecular Psychiatry.
“Addictions share similar pathways in the brain — food 
addiction, alcohol addiction, drug addiction. If this drug can 
block the ghrelin receptors, even if you have a high ghrelin 
level, your ghrelin receptors become numb and do not 
respond to the hunger signal,” said Akhlaghi, co-principal 
investigator on the study. “In 12 patients, there was a 
statistically significant reduction in alcohol craving and food 
craving. We cannot say this is a cure; we can say it is a 
promising therapy.”
The researchers are now working on a larger placebo-con-
trolled clinical trial which will further test the medication on 
patients with alcohol use disorder. Researchers will study 
the effects of the medication on patients’ alcohol cue 
responses using functional magnetic resonance imaging to 
determine whether the drug has adequate efficacy for 
treating disorder.
“We cannot say  
this is a cure;  
we can say it is  
a promising 
therapy.”
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Stopping Cancer Before it Starts
A person unknowingly exposed to a carcinogen may live for decades before a cancer 
diagnosis is made, giving tumors time to grow and the disease time to develop.
But what if people knew what toxins they’ve been 
exposed to in their lifetimes long before a cancer 
has begun to form? They could be screened for 
the cancers those carcinogens cause and have a 
much better chance of tackling the disease before 
it turns incurable.
URI College of Pharmacy Assistant Professor 
Deyu Li is trying to give people exactly that 
chance, leading a study to identify the mutational 
spectra of environmental toxins. Funded by the 
$2.1 Million ONES (Outstanding New Environ-
mental Scientist) Award from National Institute of 
Environmental Health Sciences, the five-year 
study examines the mutational spectra of human 
carcinogens.
“It’s often a very long time between exposure to a 
carcinogen and a diagnosis of cancer,” Li said. 
“By then, it’s often too late for the patients. But we 
can help them know way earlier than that.  
By identifying the damaging patterns 
to the genome, we could tell people 
they are at risk. They’ll have a better 
chance of living longer and living a 
better life.”
By collaborating with Professor Bongsup Cho’s 
lab in the same department, Li’s study begins with 
4-aminobiphenyl and amino-alpha-carboline. The 
former is the only known chemical that can cause 
human bladder cancer and the latter is a carcino-
gen that is formed in well-done cooked meat, 
diesel gas exhaust and tobacco smoke. He hopes 
to identify mutational spectra of the two toxins, 
with the goal of eventually mapping many other 
carcinogens. Once the mutational spectra are 
identified, people who have their genomes 
sequenced can know to watch for specific 
cancers as they age.
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Pharmacy Professor Wins $2 million Avenir Award
A pharmacy professor’s study that aims to leverage the influence of social networks or 
communities among people who use drugs for HIV treatment and prevention was selected 
for the 2018 Avenir award for HIV/AIDS research by the National Institute on Drug Abuse.
Assistant Professor Ashley Buchanan is this 
year’s awardee and will receive more than $2 
million over the next five years to fund her “highly 
innovative study,” according to NIDA.
Buchanan’s project is designed to advance HIV 
prevention and treatment research by studying 
drug users who are part of social networks or 
communities that may exert biological or social 
influence on their members. Current methodologi-
cal approaches to estimate and evaluate how 
prevention and treatment interventions permeate 
a risk network or community of drug users are 
limited. Buchanan’s research will improve the 
quality of information obtained from net-
work-based studies, helping facilitate interven-
tions by expanding the knowledge base of HIV 
preventative and treatment best practices and 
leveraging network-based effects to reduce risk 
and improve HIV prevention and treatment.    
The study will develop novel statistical methodolo-
gies to determine the best ways to reach the most 
at-risk people with treatment and information they 
need. Intravenous drug users can be supported to 
engage in less risky behaviors, such as not 
sharing injection equipment, and to get tested for 
HIV and seek treatment if needed. Successfully 
treating and educating one person helps not only 
that individual live a healthier life, but also others 
in the social network with whom he or she 
interacts.
“The goal ultimately is developing methods that 
can help us better understand how these social 
connections play a role in the effectiveness of 
biological and educational interventions,” 
Buchanan said. “The bottom line is understanding 
when these effects differ depending on what the 
individual’s role is in the network. How can you 
design future interventions to better leverage the 
beneficial spillover?”  
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Mind Over Matters
Six weeks of yoga and meditation proved a potent 
prescription for students who participated in a 
recent College of Pharmacy study.
Conducted by pharmacy student John Hoolahan ’19, 
Clinical Associate Professor Virginia Lemay and Assistant 
Professor Ashley Buchanan, the study, titled “Samyama: 
Stress, Anxiety, Mindfulness: A Yoga and Meditation 
Assessment,” found students reporting increased mindful-
ness coupled with decreased stress and anxiety levels after 
a month-and-a-half of weekly practice. Seventeen students 
participated. About half of those were pharmacy students.
The students undertook a one-hour vinyasa yoga class, 
followed by guided meditation. Students completed ques-
tionnaires at the beginning and end of the program, 
assessing their stress, anxiety and mindfulness levels.
Hoolahan, who is also a Reiki master, said the study 
evolved out of conversations he had with Lemay about 
integrating his spiritual life with his academic and profes-
sional pursuits. “I was coming out of a time 
when I was very unsure as to what I wanted 
to be on this Earth for,” Hoolahan said. 
“This showed me I’m capable of merging 
these two worlds that I’ve found.”
The popularity of the study — and a spin-off weekly medita-
tion class — have the trio considering what they might do 
next. Hoolahan would like to do more research and find a 
larger space to make yoga, meditation and Reiki available 
to more people.
The need is real, the three agreed.
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Student Earns National Award for Work in Public Health 
URI College of Pharmacy student Paige Ethier earned national recognition for her  
commitment to public health and her work with underserved populations from the  
United States, Public Health Service.
STUDENTS
Prepared to be health  
care leaders
URI pharmacy student Paige Ethier.
Lt. Jessica Newman presented the P4 student with the 
Excellence in Public Health Pharmacy Award in Dean E. 
Paul Larrat’s office April 18. The Annual Excellence in 
Public Health Service presents the award to increase the 
public’s awareness of the critical role pharmacists play in 
promoting healthy communities.
“This year’s awardee is recognized for her extensive work 
with medically underserved populations, including carrying 
out educational campaigns for underserved residents of 
Rhode Island, staffing immunization clinics and health 
screening for incarcerated inmates and developing educa-
tional programs for native American tribes,” Lt. Jessica 
Newman said. “Pharmacists are trusted health care 
providers who have the capability to produce a positive 
impact on our nation’s health.”
Ethier, a South Kingstown, R.I., native, has traveled around 
the country working with Native American tribes, including 
the Cocopah and Quechan tribes in Yuma, Arizona, and the 
Cherokee tribe in Oklahoma. She worked as a pharmaceu-
tical intern, helping run immunization clinics, screening for 
such conditions as diabetes and hypertension, and 
spreading public awareness to prevent the conditions. She 
has also done similar work in prisons around the country, 
Ethier said she hopes to continue in a career in public health.
Pharmacy Professor Brett Feret nominated Ethier for the 
award to recognize the work she has already completed 
toward that goal.
“I know she is committed to public health,” Feret said. 
“Looking at all she’s done this year and all the work she’s 
done in the public health sphere, it just made sense to 
nominate her.”
“Pharmacists are 
trusted health care 
providers who 
have the capability 
to produce a 
positive impact  
on our nation’s 
health.”
ANNUAL REPORT 2018 / 11
College Confers 165 Degrees
Dean E. Paul Larrat urged graduates to always “act 
to maintain that trust” patients need to have for their 
pharmacists as they embark on their careers after 
165 of them received their degrees Sunday, May 20.
“There’s a psychological component to all medications,” 
Larrat told the group in his commencement address. “Why 
is this? There’s that psychological effect because patients 
trust that that medication is going to work; they trust their 
prescriber; they trust the person that dispenses and 
supplies them with pharmaceutical information. In short, 
they trust the system from which that medication comes. 
They trust you; each and every one of you. So my 
challenge to you today as you leave is to always act to 
maintain that trust. Always act in a professional manner. 
Always be trustworthy. Indeed, it’s really the health of the 
patients that will benefit from that trust.”
Earlier, graduate Paige Lovellette led her now former 
classmates in one final “Rhody, Rhody, Rhody” chant while 
delivering the student commencement address. Lovellette 
reflected on her years at the university with an eye to the 
future, noting that while graduation is an end, “commence-
ment is a beginning.” She urged her fellow graduates to 
“dare to be different” and embrace all opportunities that will 
come their way.
“The University of Rhode Island has given you an incredible 
instrument, and it is important to take what you have 
learned these past six years and continue to grow and 
blossom,” Lovellette said. “We are at a time in our country 
when anyone, from any place, at any age can make a 
difference. There will be times when opportunities present 
themselves. Do not be afraid to take them. Every opportuni-
ty brings us a chance to make that difference. Create those 
opportunities and vow to be a difference maker.”
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Leadership, Service and Care
Reflecting on his college career, Joseph Nardolillo remembers being shy and not very 
involved at the start of his freshman year. But his time within the College of Pharmacy has 
taught him to take advantage of every opportunity, on campus and beyond.
Nardolillo’s impressive work has taken him to 
pharmacies and medical centers throughout 
Rhode Island, and to underserved communities 
around the world. His time at URI has given him 
the opportunity to volunteer his services in Jamaica, 
Ghana and Guatemala, an experience he said has 
shaped him as a pharmacist and a person. 
On his first mission trip to Kingston, Jamaica, 
Nardolillo said he was basically operating as a 
“pharmacist out of a suitcase. It was a unique 
experience because pharmacists often aren’t 
brought along and are many times undervalued 
on these types of trips,” he said. “The pharmacist 
has a way bigger role than just handing out a 
prescription. You have to make sure that they’re 
dosing correctly; you have to make sure that it’s 
not going to harm a patient.”
Giving back has been a huge part of Nardolillo’s 
URI experience, and it’s one he’ll be continuing 
after graduation when he begins his residency at 
Indian Health Services in New Mexico. His 
inspiration to apply for such a prestigious program 
comes from the quality of education he’s received 
in the College of Pharmacy.
Nardolillo said he feels prepared because of the 
strong patient care emphasis the College instills 
in students. His countless hours spent learning 
material in a classroom, and teaching it as a 
graduate student, were essential to his career, 
but being taught how to apply that knowledge in 
situations like in Jamaica has been central to his 
education. 
In New Mexico, where Nardolillo will fully manage 
his patients and have one-on-one interactions, 
the skills he’s gained from opportunities he’s had 
here will come into play every day.
“It’s not just a classroom thing,” Nardolillo said. 
“It’s not just getting a lecture and learning 
material. It’s how are you going to use that 
material in the real world? What skills do you also 
need to build here to then be able to put to use 
out there? You can have all the information in the 
world, but if you can’t talk to a patient, if you can’t 
talk to a doctor, if you can’t be connectable and 
want somebody to listen to you and want 
somebody to engage with you, that knowledge is 
going to waste.”
 His inspiration to 
apply for such a 
prestigious program 
comes from the 
quality of education 
he’s received in the 
College of Pharmacy.
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Students, Faculty Members 
Promote Pharmacy at Statehouse
Dozens of URI Pharmacy students joined several 
faculty members and Dean E. Paul Larrat at the 14th 
annual Face of Pharmacy Day at the Rhode Island 
Statehouse in April.
Created by the Rhode Island Pharmacist’s Association, the 
Face of Pharmacy Day gives pharmacists and pharmacy 
teachers and students the chance to promote their profes-
sion to state leaders and advocate legislators for or against 
pharmaceutical issues, according to URI Pharmacy 
Professor Anita Jacobson.
“It’s a chance for legislators to see pharmacists outside the 
pharmacy,” Jacobson said. “It lets them see what we do, 
like blood pressure and BMI — the non-traditional roles 




A small business led by URI 
College of Pharmacy graduate 
students is among the latest 
recipients of a $50,000 Innovation 
Voucher fund awarded by the 
Rhode Island Commerce Corp. to 
promote research and innovation.
Alcinous Pharmaceuticals, LLC, a 
pharmaceuticals start-up founded by 
three URI College of Pharmacy 
doctoral students, uses computer-aid-
ed drug design to build a large library 
of promising drug molecules that could 
be used to develop cancer therapies 
that are highly effective and well 
tolerated. Alcinous is partnering with 
Brenton DeBoef, associate professor in 
the URI Department of Chemistry. The 
project goal is to prove that molecules 
designed using computers can be 
produced in a laboratory.
The Innovation Voucher program 
promotes research and development 
partnerships among small businesses 
and subject matter experts. The 
incentive program awards up to 
$50,000 to businesses with fewer than 
500 employees and their knowledge 
partners — often hospitals, colleges or 
universities. The program issued its 
first vouchers in January 2016 and has 
since granted 43 awards.
Nicholas DaSilva, Kenneth Rose and 
Benjamin Barlock.
14 / URI COLLEGE OF PHARMACY
FACULTY
Expertise earns  
National Recognition
Millions in Research Funding for URI Neuroscientist
A $3.3 million grant from the National Institutes of Health will support a University of 
Rhode Island neuroscientist’s research to identify early-stage biomarkers for a brain 
disease often found to coexist with Alzheimer’s disease.
The five-year grant was awarded to William Van Nostrand, 
Hermann Professor of Neuroscience at URI’s College of 
Pharmacy and George & Anne Ryan Institute for Neurosci-
ence. The funding will help fill a critical research niche in 
early detection of cerebral amyloid angiopathy, a disease in 
which amyloid deposits form in small and medium blood 
vessels in the central nervous system, contributing to 
dementia and brain hemorrhages. Although the disease is 
common in the elderly, it often isn’t diagnosed until its late 
stages, when bleeds can be detected by brain imaging.
“Early and accurate diagnosis of this condition has 
remained elusive,” Van Nostrand said. “There is a need for 
biomarkers for early stages of disease prior to the presence 
of lesions detected by neuroimaging. The purpose of this 
project is to fill this void by developing and validating robust 
biological fluid markers for CAA.”
The project, is being conducted in collaboration with 
Professor Marcel Verbeek at Radboud University Medical 
Center in Nijmegen, Netherlands, based on previous work 
by the Verbeek and Van Nostrand labs that identified 
potential cerebral amyloid angiopathy biomarkers in brain 
tissue. A biological fluid marker not only could potentially 
provide an earlier, more accurate diagnosis of the disease, 
but could also help guide treatment options, particularly in 
therapies where the disease represents a heightened risk of 
hemorrhage.
Van Nostrand is noted for being the 
first researcher to purify and charac-
terize amyloid precursor protein, the 
progenitor of the amyloid-beta 
protein that forms hallmark plaques 
in Alzheimer’s disease. “Our goal is 
ultimately to identify mechanisms of 
disease that could be targets for new 
treatments,” he said.
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Deyu Li Announced as  
Avedisian Endowed Chair
Professor Deyu Li is known around the College as a 
dedicated, engaging teacher. He is known as a 
talented researcher making significant break-
throughs in DNA science and cancer treatment. He is 
now also known as the Paramaz Avedisian Endowed 
Chair in Medical Organic Chemistry.
Li has been chosen for the position named for 1954 URI 
graduate Paramaz Avedisian, Dean E. Paul Larrat has 
announced, part of the $5 million gift Edward Avedisian 
made to the college in 2017. Li is the perfect person to 
continue the legacy of his late brother, a dedicated pharma-
cist and chemist, Edward Avedisian said.
“He’s got a great rapport with students; he’s doing a great 
job bringing in research grants; and he’s producing impres-
sive results in the lab. A guy like that can draw in the top 
students,” Avedisian said. “When you’ve got curiosity, 
creativity and you’re willing to work, huge developments can 
come out of it.”
Li is the first named to the endowed chair, intended to help 
build a team of scientists across multiple disciplines to work 
toward the goal of finding better therapies for disease and 
better treatments for patients. 
“We’re gradually advancing toward the end goal of finding 
better therapies, but this is not a one-day study. It takes 
time. The endowed chair will help give us the time and 
support to get there,” Li said. “It’s always been my goal to 
study disease, find better drugs and improve treatment. This 
gives me a lot of confidence and support to pursue this goal 
I’ve had for a long time.”
Dean Larrat shares that confidence in Li, expecting the 
Avedisian Chair will help the young professor succeed in his 
mission.
“Deyu is truly one of the rising stars not just at URI but 
throughout the entire pharmaceutical development industry,” 
Larrat said. “He is an engaging teacher who will continue to 
attract the top students to the College and to his lab. He has 
already proven himself to be among the most talented 
researchers in his field. I have no doubt the many break-
throughs Deyu will achieve will impact the medical 
community for decades to come.”
“We’re gradually 
advancing 
toward the end 
goal of finding 
better therapies, 
but this is not a 
one-day study. It 
takes time. The 
endowed chair 
will help give us 
the time and 
support to get 
there.”
  – Deyu Li
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High Honor for Ryan  
Institute Director
Paula Grammas, College of Pharmacy professor  
and executive director of the University of Rhode 
Island’s George & Anne Ryan Institute for  
Neuroscience has been elected a Fellow of  
the American Association for the Advancement of 
Science in recognition of her pioneering research 
into neurodegenerative conditions, including  
Alzheimer’s disease.
Grammas is part of a prestigious group of scientists, 
including five Nobel Laureates, selected as 2017 Fellows 
for “their contributions to science and technology, scientific 
leadership and extraordinary achievements across disci-
plines.” She is being recognized “for services to neurosci-
ence, particularly in developing a novel approach to 
understanding the pathology of Alzheimer’s disease and 
explaining research to the community,” according to the 
award letter from Rush D. Holt, chief executive officer. 
Grammas is best known for her research into the role that 
blood vessels and inflammation play in the development of 
neurodegenerative diseases.
“I am honored to be recognized by the American Associa-
tion for the Advancement of Science, which has been a 
force for good in supporting the work of scientists and 
fostering innovation and collaboration among scientists, 
engineers and educators around the globe,” Grammas said. 
“This acknowledgement is particularly meaningful coming 
from my peers.”
Founded in 1848, the Association is the world’s largest 
multidisciplinary scientific society. Past Fellows include 
inventor Thomas Edison, anthropologist Margaret Mead 
and astronomer Maria Mitchell.
Grammas has received numerous awards for her research. 
She has been the principal investigator or co-investigator 
on more than $26 million in research grants from the 
National Institutes of Health, the Alzheimer’s Association, 
the American Foundation for AIDS Research, and other 
agencies. She has published more than 143 peer-reviewed 
research papers and is the recipient of the Zenith Award 
from the Alzheimer’s Association, recognizing her as one of 
the nation’s leading researchers on Alzheimer’s disease.
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Rhode To Health
Mobile Health Unit brings  
care to communities.
On the Rhode to Health
The URI Health Institute, part of the 
Academic Health Collaborative, 
recently acquired a mobile health unit 
to help increase the collaborative’s 
outreach into the community. College 
of Pharmacy faculty members and 
students will take part in health 
outreach initiatives throughout Rhode 
Island, which are expected to include 
blood pressure screenings, HIV/AIDS 
screenings, flu shot clinics and more. 
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SPECIAL PROGRAMS





The market for new, better 
medications is ever-expanding, 
and the rapid expansion of the 
industry has created a critical 
demand for skilled profession-
als (from equipment operators 
to advanced technical and 
quality assurance personnel) 
and additional infrastructure to 
support drug development and 
manufacturing.
URI’s College of Pharmacy is 
helping fill that void with its state-of-
the-art Good Manufacturing Practice 
(GMP) Facility. Located in the 
basement of Avedisian Hall, the 
7,000 square-foot clean room has 
the purity and sterility of a hospital 
operating room, necessary for 
producing medications. A series of 
fans and an advanced filtration 
system constantly scrub the 
environment. The air pressure of 
each interconnected room and 
laboratory is higher than the last, 
ensuring air — and the contami-
nates it carries — is constantly 
flowing out.
The facility supports the University’s 
continuing efforts to strengthen and 
expand its education, research and 
development capabilities and allows 
the limited production of pharma-
ceutical / biotechnology products. 
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The facility’s mission is to:
• Facilitate the development  
of new pharmaceutics by 
researchers at URI and their 
academic and industry partners.
• Engage private partners to 
enhance the economic 
development of the Rhode 
Island pharmaceutical and 
biotechnology industries.
• Develop a world-class 
teaching and training facility 
for faculty, students and the 
biotech/pharmaceutical 
industry.
The URI GMP Facility fills a  
critical void in the infrastructure  
for pharmaceutical development, 
manufacturing, research and 
teaching within the State of  
Rhode Island. Its services include:
• GMP operations: Assisting 
academic, government and 
industry partners with the 
manufacture of solid dose 
forms for veterinary and  
human use.
• GMP analytical testing: 
Providing pharmaceutical 
testing services, including 
turnkey stability studies.
• Education: Providing GMP 
industrial experience in drug 
manufacturing and analytical 
testing for students in various 
related undergraduate, 
graduate and adult education 
programs, as well as industry-
specific training in collaboration 
with pharmaceutical and 
biotechnology firms.
Seminar By the Sea tackles 
Trending Health Topics
With a theme of “advocating for our patients,” the 
University of Rhode Island College of Pharmacy 
Office of Continuing Professional Development 
presented its 33rd annual Seminar by the Sea 
Northeast Regional Conference in March.
The conference — March 14-16 at Gurney’s Newport 
Resort and Marina on Goat Island, Newport — brought 
together pharmacists, clinicians and students from around 
the region to discuss some of the largest issues affecting 
health care today. Training sessions during the seminar 
provided continuing education credits for pharmacists.
A host of pharmaceutical and medical professionals 
presented on such topics as the ongoing opioid crisis, 
avoiding pharmaceutical errors, the physiological impacts  
of marijuana on children and adolescents, and more. 
Continuing education credits were available in such topics 
as preceptor training and compounding best practices, and 
a panel discussion addressed the local response to drug 
supply challenges. Keynote addresses were delivered by 
Sen. Sheldon Whitehouse (D-R.I.), below, and Jake 
Nichols, CEO of Strategic Recovery Resources.
The College has scheduled the next Seminar by the Sea  
for Thursday and Friday, March 14-15, 2019, at Gurney’s in 
Newport. For more information and to register, log onto 
uri.edu/pharmacy/cpd
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Bringing URI success  
into the community
Alumnus, CVS Vice President Wins 
2018 Campbell Award
The University of Rhode Island College of Pharmacy 
presented alumnus Tom Davis, above right, with the 
Dr. Norman A. Campbell Award for Ethics and  
Excellence in Healthcare, honoring his “profound 
dedication” to the pharmacy profession and society 
as a whole.
Davis, a 1991 graduate from URI, is vice president of Pharmacy 
Professional Services for CVS, where he is responsible for the 
patient safety, quality assurance, professional practice standards 
and clinical support for the company’s retail division. He also 
leads professional practices for Omnicare, CVS Health’s long-
term care pharmacy business.
Before his 20 years at CVS, Davis worked for Brooks Pharmacy 
and as chief of the Compliance and Regulatory Section for the 
Rhode Island Division of Drug Control. He has also served on 
the Rhode Island Board of Pharmacy and in 2015 was appoint-
ed to the Rhode Island Opioid Overdose Prevention Taskforce, 
showing the commitment to quality and ethics the Campbell 
Award recognizes, according to Norm Campbell, professor 
emeritus at URI for whom the award is named.
“He has been really committed to the law and ethics throughout 
his career,” Campbell said. “He is absolutely deserving. He has 
maintained an interest in doing the right thing, which is some-
thing that isn’t always easy to do.”
Professors David Rowley and Bongsup 
Cho present 2018 Doctor of Philosophy and 
Pharmaceutical Sciences graduate Ang Cai 
with his ceremonial hood during the annual 
Hooding Ceremony in May.
Some of the Newest B.S.P.S and Pharm.D 
graduates pose with their Professors. 
Newest Alumni
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URI Graduate Dedicated to Improving Length, Quality of Life
Whether it’s studying new medications to treat Alzheimer’s disease, helping develop 
vaccines that aim to prevent the debilitating disease, or educating the next generation of 
elder care professionals, few have done more to advance the medical care of older adults 
than Dr. John Stoukides.
As director of 




Health Care, and the 
Rhode Island Mood 
& Memory Research 
Institute, Stoukides, a 
1985 URI graduate, 
has dedicated his 
professional life to 
improving not only the length, but also the quality of 
life as we age. For his contributions to the field and 
health of the community in general, Dean E. Paul 
Larrat presented Stoukides with a Distinguished 
Achievement Award in 2017.
In his 20 years practicing geriatric medicine, 
Stoukides has taken part in clinical research trials 
that have brought all FDA-approved Alzheimer’s 
medications to market. He is working to develop 
vaccines to prevent Alzheimer’s and to slow its  
progression. He is also a professor at Boston Univer-
sity and Brown University, and is a founding faculty 
member of the Rhode Island Geriatric Center at URI.
Stoukides continues his ground-
breaking research at the University, 
partnering with the Ryan Institute for 
Neuroscience to test new  
Alzheimer’s treatments using 
vascular activation. 
He has also served on the College of Nursing 
Advisory Council, participated in the creation of 
the Academic Health Collaborative and continues 
to generously support the Colleges of Pharmacy 
and Health Sciences. 
Some of the newest alumni,  
the BS - Pharmaceutical Sciences 
2018 graduates, gathered for an 
end-of-year celebration at the  
Alumni Center in May.
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GIVING
Support for College means 
0pportunities for all
GIVING ALLOCATIONS






z  Outright Gifts / 1.0%
z  New Documented Pledges / 11.3%
z  Matching Gifts / 9.0% 










z  Endowed Gifts / 90.6%
z  Operating Gifts / 6.7%





Annual Fund  $105,006 $94,446 
Endowed Gifts  $3,538,482 $70,182
Operating Gifts  $261,496 $254,696 
An honor roll of donors is published online at  
uri.edu/pharmacy/college-of-pharmacy-honor-roll/
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Development Director Named
The University of Rhode 
Island Foundation has 
announced the appoint-
ment of Eric Schonewald 
as managing director 
of development for the 
Academic Health Collab-
orative. Schonewald will 
work closely with College 
of Pharmacy Dean E. Paul 
Larrat, College of Nursing 
Dean Barbara Wolfe and 
College of Health Sciences 
Dean Gary Liguori.
Schonewald launched his 
23-year development career at Yale University School of Medi-
cine, where he ultimately served as director of development for 
the Department of Internal Medicine. While at Yale, his team 
led the School of Medicine’s educational component of the 
Yale Tomorrow capital campaign. Before accepting the position 
at the URI Foundation, he served as senior director of devel-
opment for the Bloomberg School of Public Health at Johns 
Hopkins University.
URI’s Academic Health Collaborative, launched in 2016, serves 
more than 5,000 students in nine health disciplines. The URI 
Health Institute serves as a hub for innovation, providing 
cross-disciplinary opportunities in education, research, en-
trepreneurship and service. Its work engages external health 
agencies, including hospital systems, and other universities 
and colleges in the state. 
“As society ages and confronts 21st Century diseases, there 
is a constant need to innovate and develop new and better 
medications,” Schonewald said. “The researchers here in 
the College of Pharmacy continue to meet that burden with 
ever-more creative and revealing research. But they can’t do it 
alone. Philanthropic support is absolutely essential to support 
these talented researchers as they work toward the future of 
health care.”
For more information about giving to the College of Pharmacy 
or any disciplines in the Academic Health Collaborative, contact 





z  Outright Gifts / 77.7%
z  New Documented Pledges / 18.8%
z  Matching Gifts / 0.1% 





z  Outright Gifts / 1.0%
z  New Documented Pledges / 11.3%
z  Matching Gifts / 9.0% 
z  New Planned Giving Activity / 78.8%
z  Endowed Gifts / 90.6%
z  Operating Gifts / 6.7%





z  Endowed Gifts / 73.7%
z  Operating Gifts / 20.9%





Annual Fund $121,427 $125,182
Endowed Gifts $1,685,857 $1,561,755
Operating Gifts $478,802 $316,302
The College of Pharmacy is grateful for the alumni, friends, corporations and foundations whose generosity 
supports students, faculty and essential College initiatives.  
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Why I Give: Colleen Moffitt ’88,’94 
Colleen Prior Moffitt has held several roles in the pharmaceutical industry, having worked 
in retail, hospitals, and now in drug development as a medical liaison between physicians 
and researchers at Alnylam Pharmaceuticals. The education she received in the URI 
College of Pharmacy was integral to such a diverse career.
“My pharmacy degree prepared me very well for 
the role I have now, but before, I had many other 
roles,” said Moffitt, who earned her bachelor’s 
degree in ’88 and her master’s in ’94. “It gives 
you the flexibility to practice pharmacy in a lot of 
different ways — in a hospital, in retail, in a 
research setting. I think that’s what a pharmacy 
degree prepares you for.”
The head start URI gave Moffitt has always 
inspired her and her husband, fellow URI 
graduate Chuck Moffitt, to give back, in the form 
of both time and money. Her service to the 
College began while she was a master’s degree 
candidate, helping teach pharmacy classes and 
even filling in when a professor passed away. 
She continued through the years, serving on the 
Continuing Education Advisory Committee and 
maintaining a role on the Dean’s Advisory 
Committee, which she now chairs. She contrib-
utes financially to the College’s Annual Fund.
“I’ve always tried to somehow stay involved and 
help the College,” Moffitt said. “Serving on the 
Dean’s Advisory Committee gives me the chance 
to provide the College a window into what’s going 
on in the business world. It gives the College 
perspective on what the needs may be in the 
community, and helps students prepare for those 
challenges.”
Helping students has been a prime factor in 
Moffitt’s service and giving. She makes multiple 
donations each year to the College of Pharmacy 
Annual Fund, which is the primary source of 
unrestricted, current-use money for Dean E. Paul 
Larrat to address the most urgent student or 
faculty needs at any given time.
“The Annual Fund helps provide opportunities for 
students they wouldn’t necessarily be able to 
have on their own,” Moffitt said. “Whether it’s 
going to a pharmaceutical conference or educa-
tional traveling, it gives students experiences they 
may not have been able to afford on their own. 
Those experiences are very valuable for 
students.”
Being able to help the next generation of health-
care workers is very rewarding to Moffitt, who 
would encourage anyone in the community — 
specifically those who have benefitted directly 
from the College or the University — to support 
URI the best they can.
“We all get millions of envelopes every year, it 
seems, and there are competing interests, so I’ve 
been more thoughtful about who I give to,” said 
Moffitt, who lives in nearby Wakefield, R.I. “I want 
to donate to somewhere I can directly feel the 
impact, and URI is that. It’s such a positive 
element in our community, and that’s why I 
support the University. I would encourage anyone 
to. It doesn’t have to be a lot; every little bit helps. 
Just get in the habit.”
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TIME + TALENT
Our College of Pharmacy community is indebted to a vast network of alumni,  
partners and friends who dedicate their time and expertise to support our mission.
BSPS ALUMNI MENTORS
Matthew Alcusky ’14
Stephen J. Allen ’76
Richard Bianco ’86
Jeffrey E. Cehelsky ’87
Susan Johnson ’81




















































































































































































































































































































































































































































COLLEGE OF PHARMACY 
ADVISORY BOARD
Colleen Prior Moffitt ’88, M.S. ’94, 
Chair
Rich Krupski ’80,  
Vice Chair
Dea Belazi, Pharm.D, ’01
Norman Campbell, Ph.D. ’57, 
Christine M. Collins ’90
Ewa Dzwierzynski, Pharm.D. ’96
George Grandolfi, Ph.D. ’81
Heather Larch ’99
Justina Molzon ’73, M.S. ’76
Nancy C. Motola, Ph.D. ’83
Henrique T. Pedro ’76
Eleanor Perfetto ’90, M.S. ’88
Susan Petrovas
Lynn Pezzullo ’91
Robert W. Potter Jr. ’83
Edward Quinlan ’71
Edward M. Rudnic ’78, Ph.D. ’83
Sarah Thompson
John Zevzavadjian ’88
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COP Advisors: ‘The People I Go to’
When Dean E. Paul Larrat needs help with a College 
project, advice on pharmaceutical issues, a sounding 
board when making decisions, or anything else to 
help the College succeed, he knows where to turn: 
the College of Pharmacy Advisory Board.
“They’re the people I go to all the time, for simple things like 
finding a spot for a student internship, or more complicated 
things like consulting on technical issues,” Larrat said. “They 
act as consultants, cheerleaders, ambassadors, advisors for 
our faculty — they do it all.”
Advisory Board Vice Chairman Richard Krupski ’80 credits the 
College of Pharmacy with the success he has had over the 
years. The vice president of Employee Benefits for Hilb Group 
New England has worked in the health care space his entire 
career, for such entities as Blue Cross Blue Shield, Care New 
England and Promark LLC. He wanted to find a way to give 
back to the College that had given him so much. Helping the 
College attract top talent to URI, continually bring in research 
funding and remain “in lockstep” with the pharmaceutical 
industry beyond the university are just some of the ways the 
Advisory Board helps with the College’s success, he said.
“Being part of the committee, for me, is part of giving back. 
While you look back on your experiences, you also want to 
pay it forward,” Kurpski said. “The advisory board is meant to 
be a service to the dean. The emphasis is on ‘advisory.’ We’re 
not going to create the strategic direction of the College, but 
we are going to provide input, ideas and things the dean can 
potentially utilize to better enable the College to be successful. 
It’s a great think tank of ideas. It enables the dean to direct the 
College and help it with its strategic direction.”
Peter Morgan, senior gardener who was instrumental in the 
design and maintenance of the Youngken Medicinal Garden 
outside Avedisian Hall, retired this summer but plans to  
continue volunteering in the garden.
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‘This Garden is a Work of Art’
The Friends of the Garden rededicated the Heber W. Youngken Medicinal Garden in June, recognizing 
its 61st year and fifth year located outside Avedisian Hall, home of the College of Pharmacy. The cere-
mony served a dual purpose, also bidding farewell to longtime Senior Gardener Peter Morgan,  
who retired after more than 30 years with the College. Peter was instrumental in the design and mainte-
nance of the garden, whose bounty produces plants that are not only beautiful, but also hold medicinal 
properties.
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GLOBAL IMPACT




College of Pharmacy Dean E. Paul 
Larrat joined fellow deans from the 
Academic Health Collaborative 
Gary Liguori (Health Sciences) and 
Barbara Wolfe (Nursing), along 
with about a dozen students in 
Indonesia for a J-Term learning 
and teaching trip. 
The group visited Bali, Jakarta and Yog-
yakarta, touring community health cen-
ters, conducting blood pressure screen-
ings and relaying information on stroke 
and asthma prevention. The students 
collaborated with Indonesian pharma-
cy students and recent graduates from 
Universitas Islam Indonesia to create 
presentations regarding stroke prevention 
and education.
“The students were committed to making 
their time over there valuable,” Larrat 
said. “They were willing to enmesh them-
selves in Indonesian culture, which really 
enhanced their experience. It was a great 
cultural exchange and a really valuable 
learning experience for them and us.”
Pharmacy Dean E. Paul Larrat, center 
joined fellow deans Barbara Wolfe (Nursing) 
and Gary Liguori (Health Sciences) on a 
J-Term trip to Indonesia in January.
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Learning in 3D
The Dr. Ernest Mario 3D Visualization Auditorium 
takes the College’s use of  3D technology to a new 
level with a huge IMAX-like projection system, 
delivering 3D content ranging from the molecular 
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